| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/24/2011 | US7947511 Intensified neutral loss tags and use thereof in mass spectrometry |
| 05/24/2011 | US7947509 Optoelectronic detection system |
| 05/24/2011 | US7947507 Analysis of sulfated polysaccharides |
| 05/24/2011 | US7947506 Protein detection and quantitation using hydroxyquinolone dyes |
| 05/24/2011 | US7947505 Method for testing efficacy of antithrombotic agent |
| 05/24/2011 | US7947504 Tumor marker for pancreatic cancer and method of testing the same |
| 05/24/2011 | US7947503 Monitor and methods for characterizing airborne particulates |
| 05/24/2011 | US7947500 Liquid crystalline substrates for culturing cells |
| 05/24/2011 | US7947490 Recording assay device |
| 05/24/2011 | US7947486 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 05/24/2011 | US7947479 Bardet-Biedl susceptibility gene and uses thereof |
| 05/24/2011 | US7947466 Fluorescence based screening assays are provided that allow for the for identification of agents that selectively bind to a ligand-gated ion channels (LGIC); fluorescence resonance energy transfer (FRET) |
| 05/24/2011 | US7947465 Simultaneous assay for determining drugs |
| 05/24/2011 | US7947464 Method for identifying regulatory T cells |
| 05/24/2011 | US7947463 Diagnosing cancer; measure antibody inhibitor, compare to control, reduced amounts of inhibitor indicates receptivity to cancer |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947461 Colloidal silica particle containing light-absorbing substance, nano light-absorbing material, absorption labeling nanobead kit, and method for detection or quantification of biological molecule using the colloidal silica particle containing light-absorbing substance |
| 05/24/2011 | US7947460 Diagnosing/prognosing nut allergies; immunodiagnostics |
| 05/24/2011 | US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/24/2011 | US7947458 Placental human neurokinin B precursor |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947449 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/24/2011 | US7947443 DNA and RNA conformational switches as sensitive electronic sensors of analytes |
| 05/24/2011 | US7947439 Detection of bovine viral diarrhea virus in tissue samples |
| 05/24/2011 | US7947438 Using presence of viral gp48 polypeptide in follicles of cattle as diagnostic indicator of viral disease; veterinary medicine |
| 05/24/2011 | US7947436 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 05/24/2011 | US7947276 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 05/24/2011 | US7947255 Fluorescent substrates for neurotransmitter transporters |
| 05/24/2011 | US7947254 Method of detecting a neuromyelitis optica specific-autoantibody by an antigenic aquaporin-4 polypeptide |
| 05/24/2011 | US7947236 unitary separator having an overall density between the heavier and light fractions capable of moving between the fractions upon centrifugation, and sealing the fractions from one another when centrifugation ends. |
| 05/24/2011 | US7947226 Catalytic combustion type gas sensor, sensing element and compensating element for the same |
| 05/24/2011 | US7947225 Automated test tube cap removal apparatus |
| 05/24/2011 | US7947224 Using colorimetric analysis to determine concentration of cells |
| 05/24/2011 | US7946485 Method of maintaining product status with invisibly coded interface |
| 05/24/2011 | US7946155 Method for quantitatively determining unbound metal in formulations containing chelates |
| 05/24/2011 | US7946154 Hydraulic fluid determination system and method |
| 05/24/2011 | US7946152 Apparatus and method for measuring the concentration of organic gas |
| 05/24/2011 | CA2599747C A method, device and system for enumeration of white blood cells |
| 05/24/2011 | CA2538305C Apheresis device |
| 05/24/2011 | CA2453001C Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling |
| 05/24/2011 | CA2450467C Methods for modulating bladder function |
| 05/24/2011 | CA2445911C Methods for the identification of antiviral compounds |
| 05/24/2011 | CA2402534C Mrna amplification |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2375115C Method for separating cells using immunorosettes |
| 05/24/2011 | CA2374215C New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 05/24/2011 | CA2350839C Method and apparatus for performing a lateral flow assay |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2342064C Long wave length absorbing bacteriochlorin alkyl ether analogs |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2338751C Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/24/2011 | CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/20/2011 | CA2719219A1 System and method for detecting features on a laminated veneer lumber billet |
| 05/19/2011 | WO2011060380A1 Pik3ca mutation status and sash1 expression predicts synergy between lapatinib and an akt inhibitor in her2 positive breast cancer |
| 05/19/2011 | WO2011060361A1 Risk factors and prediction of myocardial infarction |
| 05/19/2011 | WO2011060329A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis |
| 05/19/2011 | WO2011060328A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| 05/19/2011 | WO2011060298A1 Rational design of regenerative medicine products |
| 05/19/2011 | WO2011060240A1 Copy number analysis of genetic locus |
| 05/19/2011 | WO2011060205A1 Methods, compositions, and assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease |
| 05/19/2011 | WO2011060203A1 Methods for assessing the immune system in a patient |
| 05/19/2011 | WO2011060184A1 Cervical cancer screening by molecular detection of human papillomavirus-induced neoplasia |
| 05/19/2011 | WO2011060182A1 Monoclonal antibodies against gmf-beta antigens, and uses therefor |
| 05/19/2011 | WO2011060098A1 Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis |
| 05/19/2011 | WO2011060051A1 Methods for treating glioblastoma |
| 05/19/2011 | WO2011060015A1 Methods and compositions for detecting target proteins |
| 05/19/2011 | WO2011059972A1 Cell surface marker expression in hematopoietic stem cells and progenitors for the diagnosis, prognosis, and treatment of myelodysplastic syndromes |
| 05/19/2011 | WO2011059721A1 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
| 05/19/2011 | WO2011059670A1 Underfill recognition system for a biosensor |
| 05/19/2011 | WO2011059649A1 Method for diagnosing liver fibrosis |
| 05/19/2011 | WO2011059512A1 Filtration device for assays |
| 05/19/2011 | WO2011059490A1 Heart aging biomarkers and methods of use |
| 05/19/2011 | WO2011059482A1 Plasmodium falciparum hla class i restricted t-cell epitopes |
| 05/19/2011 | WO2011059459A1 Physical characterization of oligonucleotides conjugates |
| 05/19/2011 | WO2011059453A1 Methods for producing surface bound oligonucleotide on solid substrate and uses thereof |
| 05/19/2011 | WO2011059403A1 Test kit and method for quantitative determination of thiuram compounds in a sample |
| 05/19/2011 | WO2011059401A1 Method and apparatus to perform hydrogen-deuterium exchange |
| 05/19/2011 | WO2011059397A1 Self-flowing measuring system |
| 05/19/2011 | WO2011059130A1 Duplex vibriocidal assay for simultaneously measuring vibriocidal serum antibody valence of combined vibrio vaccine |
| 05/19/2011 | WO2011059076A1 Magnetic reagent, magnetic reagent kit, method for treating magnetic carriers and treatment device therefor |
| 05/19/2011 | WO2011059066A1 Method for identification of plant species, plant hybrid species and parental species of plant hybrid utilizing plant metabolite, and method for planting plant identified by the method |
| 05/19/2011 | WO2011058994A1 Nonhuman animal model of type 2 diabetes |
| 05/19/2011 | WO2011058993A1 Method for screening for novel bone resorption inhibitor |
| 05/19/2011 | WO2011058958A1 Composition for stabilization of hemoprotein, and method for stabilization of hemoprotein utilizing same |
| 05/19/2011 | WO2011058721A1 Substrate with photo-controllable cell adhesion property, method for analyzing and fractionating cells, and device for analysis and fractionation of cells |
| 05/19/2011 | WO2011058655A1 Blood property analysis system |
| 05/19/2011 | WO2011058509A1 Method and kit for the prevention and/or the monitoring of chemioresistance of leukaemia forms |
| 05/19/2011 | WO2011058508A2 New compositions for the treatment of chemioresitant and/or potentially chemioresistant leukaemias |
| 05/19/2011 | WO2011058364A1 Method of treatment and screening method |
| 05/19/2011 | WO2011058335A1 Sgii as a prognostic marker in conditions which require critical care |
| 05/19/2011 | WO2011058308A1 Optical sensor |
| 05/19/2011 | WO2011058280A1 Human fertility test using dpy19l2 |
| 05/19/2011 | WO2011058182A1 Osteopontin-conditioned medium for the treatment of vascular diseases |
| 05/19/2011 | WO2011058175A1 Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer |